Skip to results
Modify your search
NARROW
1-20 of 94
Authors: Michael Lim
Journal Article
Molecular-based decision-making in glioblastoma surgery: When to aim for supramaximal resection Get access
Neuro-Oncology, noaf062, https://doi.org/10.1093/neuonc/noaf062
Published: 03 March 2025
Journal Article
The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae174, https://doi.org/10.1093/noajnl/vdae174
Published: 12 November 2024
Journal Article
TMIC-07. TRIPLE COCKTAIL IMMUNOMODULATION OF TUMOR DRAINING LYMPH NODES RESULTS IN SYNERGISTIC REVERSAL OF IMMUNOSUPPRESSION AND IMPROVED OVERALL SURVIVAL IN A MURINE GLIOBLASTOMA MODEL Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii298, https://doi.org/10.1093/neuonc/noae165.1185
Published: 11 November 2024
Journal Article
TMIC-32. INFIGRATINIB INHIBITION OF THE THBS1 PATHWAY IN MELANOMA BRAIN METASTASIS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii305, https://doi.org/10.1093/neuonc/noae165.1210
Published: 11 November 2024
Journal Article
LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii1, https://doi.org/10.1093/neuonc/noae165.1302
Published: 11 November 2024
Journal Article
IMMU-33. REPROGRAMMING OF MYELOID CELL METABOLISM VIA HEME OXYGENASE-1 INHIBITION POTENTIATES ANTI-TUMOR IMMUNITY IN A MURINE GLIOMA MODEL Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii159–viii160, https://doi.org/10.1093/neuonc/noae165.0626
Published: 11 November 2024
Journal Article
CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii104–viii105, https://doi.org/10.1093/neuonc/noae165.0406
Published: 11 November 2024
Journal Article
EPID-28. TRENDS IN LOW GRADE GLIOMA PROGNOSIS AND THE EVOLVING IMPACT OF GROSS TOTAL RESECTION ACROSS FIFTY YEARS: A MULTICOHORT ANALYSIS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii144, https://doi.org/10.1093/neuonc/noae165.0564
Published: 11 November 2024
Journal Article
IMMU-13. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.384
Published: 18 June 2024
Journal Article
Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdad169, https://doi.org/10.1093/noajnl/vdad169
Published: 10 January 2024
Journal Article
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v97–v98, https://doi.org/10.1093/neuonc/noad179.0366
Published: 10 November 2023
Journal Article
RTID-07. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v260, https://doi.org/10.1093/neuonc/noad179.0998
Published: 10 November 2023
Journal Article
CTIM-03. LONG TERM FOLLOW-UP OF A PROSPECTIVE SAFETY AND TOXICITY STUDY OF IMMUNE CHECKPOINT INHIBITOR THERAPY INITIATED 8 DAYS PRIOR TO RADIOSURGERY FOR MELANOMA BRAIN OR SPINE METASTASIS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v61, https://doi.org/10.1093/neuonc/noad179.0243
Published: 10 November 2023
Journal Article
TMIC-38. MITOCHONDRIAL ATP BIOGENESIS REGULATED BY VDAC1 IN TMEM119+ TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES MEDIATES HIGH-GRADE GLIOMA GROWTH Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v286, https://doi.org/10.1093/neuonc/noad179.1104
Published: 10 November 2023
Journal Article
QLTI-12. ADULT NEURO-ONCOLOGY TRIAL LANDSCAPE IN THE UNITED STATES OVER FIVE DECADES Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v247, https://doi.org/10.1093/neuonc/noad179.0950
Published: 10 November 2023
Journal Article
THU588 Sparing Confirmatory Testing In Primary Aldosteronism: The Combination Of Renin, Aldosterone And Potassium Levels Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.586, https://doi.org/10.1210/jendso/bvad114.586
Published: 05 October 2023
Journal Article
Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic Open Access
in
BJS Open
BJS Open, Volume 7, Issue 5, October 2023, zrad079, https://doi.org/10.1093/bjsopen/zrad079
Published: 05 September 2023
Journal Article
BSBM-17 NOVEL VALIDATED PATIENT-DERIVED MODELS OF A RECTAL CANCER BRAIN METASTASIS Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii4, https://doi.org/10.1093/noajnl/vdad070.013
Published: 04 August 2023
Journal Article
SYST-32 A NOVEL APPROACH TO TARGET TREG-MEDIATED IMMUNOSUPPRESSION IN GBM Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii34, https://doi.org/10.1093/noajnl/vdad070.132
Published: 04 August 2023
Journal Article
IMMU-05. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i50, https://doi.org/10.1093/neuonc/noad073.192
Published: 12 June 2023
